This inventor holds 1 USPTO granted patent. Top assignee: King Faisal University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Gabriella Marucci: Innovator in Pharmaceutical Compounds
Introduction
Gabriella Marucci is a prominent inventor based in Al-Ahsa, Saudi Arabia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds that target adenosine receptors. Her work is crucial in addressing various health conditions, including inflammation and cancer.
Latest Patents
Gabriella holds a patent for her invention titled "7-isopropyl 1,2-dimethyl 3-(substituted benzoyl)indolizine-1,2,7-tricarboxylates as adenosine receptor active compounds." This patent encompasses a method for synthesizing these compounds, a pharmaceutical composition that includes them, and methods for their application. The compounds identified as adenosine A receptor (AAR) modulators are particularly useful in treating conditions such as rheumatoid arthritis, psoriasis, fatty liver diseases, and various pathological conditions of the central and peripheral nervous systems.
Career Highlights
Gabriella is affiliated with King Fahd University of Petroleum and Minerals, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to advancements in drug development and therapeutic applications.
Collaborations
Gabriella has collaborated with notable colleagues, including Katharigatta N Venugopala and Pran Kishore Deb. These collaborations have enhanced her research capabilities and broadened the impact of her inventions.
Conclusion
Gabriella Marucci's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also offers potential solutions for critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
